Neuraminidase Inhibitors Improve Outcome of Patients with Leukemia and Influenza: An Observational Study | Zendy

Roy F. Chemaly | Zendy; Harrys A. Torres | Zendy; Elizabeth Aguilera | Zendy; Gloria Mattiuzzi | Zendy; Maria E. Cabanillas | Zendy; Hagop M. Kantarjian | Zendy; Verónica GonzálezCalle | Zendy; Amar Safdar | Zendy; Issam Raad | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Neuraminidase Inhibitors Improve Outcome of Patients with Leukemia and Influenza: An Observational Study

Author(s) -

Roy F. Chemaly,

Harrys A. Torres,

Elizabeth Aguilera,

Gloria Mattiuzzi,

Maria E. Cabanillas,

Hagop M. Kantarjian,

Verónica GonzálezCalle,

Amar Safdar,

Issam Raad

Publication year - 2007

Publication title -

clinical infectious diseases

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 3.44

H-Index - 336

eISSN - 1537-6591

pISSN - 1058-4838

DOI - 10.1086/512374

Subject(s) - medicine , neuraminidase , neuraminidase inhibitor , observational study , zanamivir , pneumonia , leukemia , oseltamivir , acute leukemia , virology , virus , covid-19 , disease , infectious disease (medical specialty)

We reviewed the records of 33 patients with leukemia who experienced influenza during the period from October 2000 to March 2004. Three (38%) of the 8 patients who did not receive neuraminidase inhibitor therapy and none of the 25 patients who received it died of influenza pneumonia (P=.001). The use of neuraminidase inhibitor therapy seems to improve the outcome of influenza in patients with leukemia.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research